CELEBREX-A SPECIFIC INHIBITOR OF CYCLOOXIGENASE-2: EFFICACY AND TOLERABILITY

CELEBREX-A SPECIFIC INHIBITOR OF CYCLOOXIGENASE-2: EFFICACY AND TOLERABILITY

Saved in:

Bibliographic Details
Main Author:	- -
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2000-04-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/1565
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CELEBREX: THE FIRST SPECIFIC INHIBITOR OF COX-2: NEW DATA
by: E L Nassonov
Published: (2000-08-01)

RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS
by: A. A. Lomonosova, et al.
Published: (2015-12-01)

CELEBREX IN TREATMENT OF VERTEBRAL PAIN SYNDROME IN SYSTEMICV LUPUS ERYTHEMATOSUS
by: N. P. Shilkina
Published: (2002-06-01)

CELEBREX IN TREATMENT OF VERTEBRAL PAIN SYNDROME IN SYSTEMICV LUPUS ERYTHEMATOSUS
by: N. P. Shilkina, et al.
Published: (2002-06-01)

Celebrex in treatment of joint diseases in patients with risk factors of gastropathy and cardiovascular palhalodydevelopment
by: N. V. Chichasova, et al.
Published: (2004-02-01)

TREATMENT OF RHEUMATIC DISEASES INTERRELATION OF SELECTIVE NON-STEROIDAL ANTIINFLAMMATORY DRUG CELEBREX (CELECOXIB) AND INHIBITOR OF ENZYME WITH APF ENAP (ENALAPR1L) IN PATIENTS WITH RHEUMATIC DISEASES AND CONCOMITANT ARTERIAL HYPERTENSION
by: Yu. V. Mouraviev, et al.
Published: (2002-06-01)

PRACTICAL ASPECTS OF ADMINISTERING CYCLIN-DEPENDENT KINASES INHIBITORS: EFFICACY AND TOLERABILITY
by: E. V. Artamonova
Published: (2018-04-01)

Sulfasalazine efficacy and tolerability in rheumatic diseases
by: V. V. Badokin
Published: (2005-08-01)

The efficacy and tolerability of paroxetine (adepress), an antidepressant from a group of selective serotonin reuptake inhibitors, in psychoautonomic syndrome within anxiety-depressive disorders
by: T G Voznesenskaya, et al.
Published: (2012-06-01)

Nimulid efficacy and tolerability in patients with rheumatic diseases
by: R M Balabanova, et al.
Published: (2004-02-01)

EFFICACY, SAFETY AND TOLERABILITY OF LAMOTRIGINE IN THE TREATMENT OF EPILEPSY
by: O. A. Pylaeva, et al.
Published: (2015-10-01)

Sex‐Specific Ultraviolet Radiation Tolerance Across Drosophila
by: James E. Titus‐McQuillan, et al.
Published: (2025-02-01)

Efficacy and tolerance of selective and non-selective factor Xa inhibitors in the prevention of thrombosis in kidney disease in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N. V. Seredavkina, et al.
Published: (2019-03-01)

Correspondence re: Long-term efficacy and safety of cow's milk anaphylaxis specific immunotherapy: Allergen unresponsiveness via the Tolerance Induction Program
by: Richard L. Wasserman, MD, PhD
Published: (2025-05-01)

Applying Fc-fusion proteins to tolerize perinatally and block inhibitor formation
by: David W. Scott
Published: (2025-07-01)

A modular system to evaluate the efficacy of protease inhibitors against HIV-2.
by: Mohamed Mahdi, et al.
Published: (2014-01-01)

Efficacy and tolerability of sulthiame in the treatment of epilepsy: a literature review
by: K. Yu. Mukhin, et al.
Published: (2024-04-01)

Combined Bone Marrow and Kidney Transplantation for the Induction of Specific Tolerance
by: Yi-Bin Chen, et al.
Published: (2016-01-01)

Immunological efficacy and tolerability of vaccination in patients with noncommunicable diseases
by: O. M. Drapkina, et al.
Published: (2022-04-01)

The efficacy and tolerability of leflunomide (Arava®) in therapy for psoriatic arthritis
by: Vladimir Vasilyevich Badokin
Published: (2013-12-01)

Specific FAHFAs predict worsening glucose tolerance in non-diabetic relatives of people with Type 2 diabetes
by: Ismail Syed, et al.
Published: (2025-07-01)

EFFICACY OF SGLT-2 INHIBITORS IN THE TREATMENT OF TYPE 2 DIABETES: SINGLE CENTRE EXPERIENCE
by: Ramazan Çakmak, et al.
Published: (2025-01-01)

Efficacy of sodium-glucose co-transporter-2 inhibitors in patients with heart failure
by: E. V. Kovalenko, et al.
Published: (2021-02-01)

Comparative Efficacy and Tolerability of Treatments for Erythromelalgia: A Systematic Review
by: Abdullah S. Algarni, et al.
Published: (2025-05-01)

Specific Oral Tolerance Induction Using IFN-Gamma in 2 Cases of Food-Dependent Exercise-Induced Anaphylaxis
by: Geunwoong Noh, et al.
Published: (2013-01-01)

A General and Specific Utility-Based Adaptive Routing for Delay Tolerant Networks
by: Lei You, et al.
Published: (2014-01-01)

EFFICACY AND TOLERABILITY OF LACOSAMIDE (VIMPAT) FOR TREATMENT OF EPILEPSY IN ADULTS (A REVIEW)
by: O. A. Pylaeva, et al.
Published: (2015-04-01)

Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety
by: Bing Zhang, et al.
Published: (2025-07-01)

Tracking antigen-specific T-cells during clinical tolerance induction in humans.
by: Aamir Aslam, et al.
Published: (2010-06-01)

Efficacy and tolerability of adalimumab (humira) in patients with active rheumatoid arthritis
by: I G Salikhov, et al.
Published: (2010-12-01)

Mildronate efficacy and tolerance in chronic heart failure patients therapy
by: A. S. Galiavich, et al.
Published: (2005-10-01)

EFFICACY AND TOLERABILITY OF LEVETIRACETAM (KEPPRA®) IN THE TREATMENT OF EPILEPSY: REVIEW OF LITERATURE
by: K. Yu. Mukhin, et al.
Published: (2015-06-01)

Balsam “Mercana-Artrovit warming” — efficacy and tolerability in knee osteoarthritis
by: E S Tsvetkova, et al.
Published: (2007-10-01)

Evaluation of the efficacy and tolerability of naftidrofuryl in the therapy of chronic cerebral ischemia
by: M. N. Dadasheva, et al.
Published: (2021-02-01)

COMPARATIVE EVALUATION OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE
by: S. N. Tolpygina, et al.
Published: (2015-12-01)

Conflicting plant responses to silver nanoparticles including specific and non-specific response, tolerance mechanism and positive effect
by: Gabriela Mikesková, et al.
Published: (2025-12-01)

SPECIFIC FEATURES OF ANTI-TUBERCULOSIS CHEMOTHERAPY TOLERANCE IN THE LIGHT OF PSYCHOLOGICAL STATUS OF PATIENTS
by: N. V. Zolotova, et al.
Published: (2017-04-01)

Identification of potential SARS-CoV-2 inhibitors among well-tolerated drugs using drug repurposing and in vitro approaches
by: Betül Oruçoğlu, et al.
Published: (2025-04-01)

Minor surgical procedures during immune tolerance induction in people with hemophilia A and inhibitors: results from the Brazilian Immune Tolerance (BrazIT) study cohort
by: Ricardo Mesquita Camelo, et al.
Published: (2024-11-01)

A phase 1 study evaluating the safety, tolerability, and pharmacokinetics of the porcupine inhibitor, AZD5055
by: Xiao-Hong Zhou, et al.
Published: (2025-06-01)